One Platform. Many Applications.
BioThera isolates and characterizes plant-derived extracellular vesicles at manufacturing scale. What those vesicles are formulated into is an application question, not a platform one. Below are the areas the platform is built to serve — and how far each one has actually gone.
Characterized material, documented batch by batch.
Material
Characterized EV bulk
Plant-derived extracellular vesicles isolated at manufacturing scale, counted by Nanoparticle Tracking Analysis and characterized against the MISEV2023 marker framework.
Documentation
Batch-specific CoA
Every batch ships with its own Certificate of Analysis: particle concentration, EV marker panel, and contamination screen. MISEV2023 disclosures available on request.
Logistics
Cold-chain delivery
Shipped directly from the BioThera Solutions facility in Ottawa, Ontario, in cold-chain packaging sized to the destination. No distributor handoff.
Where the platform applies — and how far it has gone.
Maturity reflects how far BioThera has taken each area, not what extracellular vesicles are claimed to do in the literature. Areas marked as research directions have no BioThera product and no published timeline.
Skincare & dermocosmetics
Topical formulation of characterized plant-derived EVs for professional skin care. Supplied to verified dermatology and aesthetic medicine clinics in Canada under our Vesera™ brand. Not in general distribution.
Clinical dermatology
An active safety and efficacy study is underway with practicing dermatologist partners. Clinics evaluating the material receive the batch-specific Certificate of Analysis behind every shipment.
Wound & barrier repair
EV cargo classes associated with wound healing appear in our proteomics data and in the plant-EV literature. We have characterization data; we do not yet have outcome data.
Regenerative medicine
The biomanufacturing and characterization requirements of regenerative applications are the ones this platform was engineered against. No BioThera product exists in this space.
Drug delivery
EVs are a phospholipid-bilayer delivery vehicle. Whether ours can carry an exogenous payload at specification is an open question we are equipped to answer.
Vesera™ — our dermocosmetic brand.
Vesera™ is BioThera’s dermocosmetic brand: plant-derived extracellular vesicles from Aloe barbadensis, formulated for professional skin care. It is a Health Canada-notified cosmetic, characterized to MISEV2023 on every batch. Vesera™ is one application of the platform — not the company.
Standards we manufacture to
Health Canada——化妆品法规（C.R.C., c. 869）
完全符合加拿大消费品安全法（C.R.C., c. 869）下的加拿大化妆品法规。加拿大市场已获授权。
MISEV2023——表征合规
完全符合国际细胞外囊泡学会（ISEV）发布的细胞外囊泡研究最低信息（MISEV2023）指南——全球标准。
Leaping Bunny无动物实验认证
有效认证。生产或供应链的任何阶段均无动物实验。
GMP/ISO合规制造
随着我们扩展皮肤美容与基于EV的护肤产品组合，制造工艺正积极向GMP和ISO合规方向发展。
FDA——FD&C Act / MoCRA合规
配方符合《联邦食品、药品和化妆品法》（FD&C Act，21 U.S.C. § 361）及2022年《化妆品监管现代化法》（MoCRA）的要求。进入美国市场的计划将在未来阶段实施——设施注册和完整的MoCRA合规将在当时追求。
第一个获知。
加入我们的候补名单，当Vesera™ Serum上市时，我们会通知您。我们也很乐意了解您是谁——这有助于我们优先考虑适当的访问渠道。
BioThera supplies cosmetic-grade material today. Vesera™ is a cosmetic under Health Canada Cosmetic Regulations and is not intended to diagnose, treat, cure, or prevent any disease. Application areas marked as research directions are not products, are not offered for sale, and carry no therapeutic claim.
Talk to us about supply or co-development.
Whether you need characterized EV material with documentation behind it, or want to explore an application that is not on this page, start with a conversation.
Contact the team